Fingerprint
Dive into the research topics of 'Adjuvant Everolimus in Patients with Completely Resected, Very High-risk Renal Cell Carcinoma of Clear Cell Histology: Results from the Phase 3 Placebo-controlled SWOG S0931 (EVEREST) Trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically